Voisin Consulting Life Sciences

What Voisin Consulting Life Sciences does

VCLS (Voisin Consulting Life Sciences) is a Paris-headquartered contract research organization founded in 1997 that provides integrated regulatory, clinical development, market access, and pharmacovigilance services to life sciences companies. The firm serves startups, emerging biotechs, established pharma, medtech and digital health companies, and sponsors developing treatments for rare diseases and unmet medical needs, with particular depth in biologics, ATMPs, cell and gene therapies, IVD/CDx, digital health products, microbiome products, and combination products.

The company operates across 10+ countries on 4 continents, with offices in France, the UK, Switzerland, Denmark, Finland, Sweden, the United States, China, India, and Madagascar, supported by 250+ professionals from 25+ nationalities. VCLS delivers a one-stop service portfolio spanning preclinical, early-stage clinical, late-stage clinical, registration, and post-approval stages, and runs a sub-brand called Neighborhood that provides yearlong mentorship and workspace facilities to biotech and medtech entrepreneurs in Boston, Paris, Lausanne, and London. The technology stack centers on Oracle Argus for global pharmacovigilance safety case processing and an ISO 27001 certified information security management system covering all core service lines.

VCLS generates revenue primarily through project-based professional services engagements with customized pricing per scope, therapeutic area, complexity, and duration. Its go-to-market is sales-led, relying on direct client engagement, thought leadership content (blogs, whitepapers, webinars, case studies), industry conference participation, and the Neighborhood program as a top-of-funnel developer relations channel. The firm has executed two acquisitions (Quanta Médical in 2021 and MedEngine in 2023) to expand capabilities and has entered a strategic Oracle partnership in January 2026 to scale pharmacovigilance operations.

Name

Voisin Consulting Life Sciences

Legal name

Voisin Consulting Life Sciences SAS

Website

https://voisinconsulting.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

251–500 employees

Short description

VCLS is a Paris-headquartered CRO founded in 1997 providing integrated regulatory, clinical, market access, and pharmacovigilance services to biotech, pharma, and medtech companies across 10+ countries and 4 continents.

Ownership category

akta.pro rank

Product category

Regulatory & Clinical Development Consulting (CRO)

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

akta.pro secondary industry

KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)

Keywords

• Regulatory affairs consulting
• Clinical development services
• Pharmacovigilance services
• Market access consulting
• Contract research organization

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices11 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D

Revenue model

1. Regulatory & Clinical Development Services: Professional services revenue model providingtailored regulatory strategy, clinical trial management, market access, and pharmacovigilance services to biotech, pharma, and medtech companies. Services are project-based and consultative in nature, typically scoped per client engagement with pricing based on scope, complexity, and duration of services required.
2. Neighborhood Innovation Program: Yearlong mentorship and support program for biotech and medtech entrepreneurs providing regulatory expertise, networking, and workspace facilities. Generates revenue through program fees from participating startups.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Voisin Consulting Life Sciences (VCLS) is a contract research organization that provides regulatory affairs, clinical development, market access, and pharmacovigilance consulting services to life sciences companies. The firm supports biotech, pharmaceutical, and medtech clients from preclinical stages through registration and post-approval, with tailored solutions spanning biologics, small molecules, cell and gene therapies, medical devices, combination products, and digital health products across global markets including the US, EU, and China.

Differentiator

Problem solved

Functional benefit

Brands

• Neighborhood: Healthtech innovation program by VCLS offering biotech and medtech/digital health entrepreneurs mentorship, networking, and facilities in Boston, Paris, Lausanne and London.

Products and services

• Regulatory Services
• Clinical Trials Services
• Market Access Services
• Pharmacovigilance / Vigilances Services
• CMC (Chemistry, Manufacturing and Controls)
• Neighborhood Innovation Program

Quantifiable outcome

• Successfully supported CTA submissions across 12 EU countries under FAST EU Pilot with approvals in all of them
• +1 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• OraclecoreTechnology or Integration · 26 January 2026VCLS selected Oracle Argus as its pharmacovigilance software platform to enhance global safety operations. The Oracle Argus solution enables VCLS to strengthen safety services, meet complex sponsor requirements, and scale operations to serve its expanding global client roster. The partnership provides advanced tools for processing, analyzing, and reporting adverse event cases across pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle's pharmacovigilance technology was recognized as a Leader in the IDC MarketScape 2025 assessment for life science R&D pharmacovigilance solutions.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medpace: Mid-to-large full-service CRO with strong biotech focus and integrated regulatory/clinical capabilities; a scaled comparable with overlapping customer profile (emerging and mid-cap biotech).
• ICON plc: Top-tier global CRO offering clinical, regulatory, and laboratory services; overlaps directly with VCLS's integrated drug-development offering but serves a much broader sponsor portfolio.
• Parexel International: Large global CRO with deep regulatory, clinical, and pharmacovigilance services; comparable across all VCLS service lines but at substantially larger scale and broader sponsor footprint.
• IQVIA: Largest global CRO with regulatory, clinical, real-world evidence, and pharmacovigilance services; a broad incumbent competing for the same pharma/biotech wallet with greater scale and data assets.
• Charles River Laboratories: Large CRO/CDMO with preclinical through clinical services including regulatory consulting; a broader incumbent with overlapping regulatory and clinical development capabilities.

Direct peers

• Veristat: Mid-size regulatory and biostatistics-focused CRO serving emerging biotech across oncology and rare disease; highly comparable in therapeutic specialization and sponsor segment.
• ProPharma Group: Regulatory, compliance, and pharmacovigilance consulting firm serving pharma and biotech; directly comparable as a regulatory-focused advisory peer with overlapping service lines.
• Pharmalex (Cencora): Regulatory affairs and pharmacovigilance consulting services firm; now part of Cencora but remains a focused regulatory services comparable to VCLS's core advisory offering.
• Celerion: Early-stage clinical and bioanalytical CRO with strong biotech customer base; comparable in scale and in the early-clinical/regulatory portion of VCLS's offering.
• Worldwide Clinical Trials: Mid-size global CRO offering clinical, regulatory, and biostatistics services across rare disease and emerging biotech — directly comparable in scale, customer mix, and integrated service model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/voisin-consulting-life-sciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Voisin Consulting Life Sciences